China Universal Asset Management Company’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,002
| Closed | -$42.8K | – | 509 |
|
|
2024
Q3 | $42.8K | Buy |
12,002
+4,701
| +64% | +$16.8K | ﹤0.01% | 393 |
|
|
2024
Q2 | $45.3K | Sell |
7,301
-4,615
| -39% | -$28.6K | 0.01% | 364 |
|
|
2024
Q1 | $112K | Buy |
11,916
+4,766
| +67% | +$45K | 0.01% | 364 |
|
|
2023
Q4 | $48.3K | Buy |
7,150
+5,556
| +349% | +$37.5K | 0.01% | 375 |
|
|
2023
Q3 | $7.08K | Buy |
1,594
+784
| +97% | +$3.48K | ﹤0.01% | 368 |
|
|
2023
Q2 | $2.67K | Sell |
810
-26
| -3% | -$86 | ﹤0.01% | 413 |
|
|
2023
Q1 | $2.38K | Buy |
836
+307
| +58% | +$875 | ﹤0.01% | 425 |
|
|
2022
Q4 | $3.85K | Buy |
529
+42
| +9% | +$306 | ﹤0.01% | 328 |
|
|
2022
Q3 | $4K | Buy |
+487
| New | +$4K | ﹤0.01% | 297 |
|